Spero Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Spero Therapeutics (SPRO).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

2Buy

2Hold

Consensus RatingIn-Line# Analysts4Avg. Consensus PT$6Upside to Avg. PT+374.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 14, 2026	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$5→$6
Jan 30, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$5
Dec 20, 2024	Evercore ISI Group	Josh Schimmer	Downgrade	Outperform→In-Line	$5
Dec 2, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$5
Nov 18, 2024	TD Cowen	Ritu Baral	Downgrade	Buy→Hold	—
Nov 15, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Nov 4, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$7→$5
Oct 3, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$7
Aug 6, 2024	TD Cowen	Ritu Baral	Upgrade	Hold→Buy	—
Aug 6, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Aug 6, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$7
May 16, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$7
Apr 4, 2024	Cantor Fitzgerald	Louise Chen	Maintained	Overweight	—
Mar 18, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$7
Nov 14, 2023	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$7

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Spero Therapeutics, Raises Price Target to $6

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Spero Therapeutics (NASDAQ:SPRO) with a Buy and raises the price target from $5 to $6.

Benzinga Newsdesk

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Avi Kapoor

The Analyst Verdict: Spero Therapeutics In The Eyes Of 4 Experts

Benzinga Insights

PRO
HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $5 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $5 price target.

Benzinga Newsdesk

What 4 Analyst Ratings Have To Say About Spero Therapeutics

Benzinga Insights

PRO
Evercore ISI Group Downgrades Spero Therapeutics to In-Line, Maintains Price Target to $5

Evercore ISI Group analyst Josh Schimmer downgrades Spero Therapeutics (NASDAQ:SPRO) from Outperform to In-Line and maintains the price target from $5 to $5.

Benzinga Newsdesk

Spero Therapeutics Inc

Spero Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Spero Therapeutics, Raises Price Target to $6

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

The Analyst Verdict: Spero Therapeutics In The Eyes Of 4 Experts

PRO
HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $5 Price Target

What 4 Analyst Ratings Have To Say About Spero Therapeutics

PRO
Evercore ISI Group Downgrades Spero Therapeutics to In-Line, Maintains Price Target to $5

People Also Watch

People Also Watch

Spero Therapeutics Inc

Spero Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Spero Therapeutics, Raises Price Target to $6

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

The Analyst Verdict: Spero Therapeutics In The Eyes Of 4 Experts

PROHC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $5 Price Target

What 4 Analyst Ratings Have To Say About Spero Therapeutics

PROEvercore ISI Group Downgrades Spero Therapeutics to In-Line, Maintains Price Target to $5

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on Spero Therapeutics, Raises Price Target to $6

PRO
HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $5 Price Target

PRO
Evercore ISI Group Downgrades Spero Therapeutics to In-Line, Maintains Price Target to $5